Literature DB >> 9745869

Interleukin-12 and interferon-gamma production in childhood idiopathic nephrotic syndrome.

V Stefanović1, E Golubović, M Mitić-Zlatković, P Vlahović, O Jovanović, R Bogdanović.   

Abstract

Cellular immune disturbances, and T lymphocyte function in particular, have been previously implicated in idiopathic nephrotic syndrome (INS) of childhood. There are different patterns of cytokine expression in various forms of glomerulonephritis, which suggests that local production of these peptides plays an important role in the pathogenesis and progression of glomerulonephritis. To investigate T-cell and monocyte/macrophage cytokine production in INS, interleukin-12 (IL-12) and interferon-gamma (IFN-gamma) production by peripheral blood mononuclear cells (PBMC) of 11 children with steroid-sensitive nephrotic syndrome (SSNS), 9 with focal segmental glomerulosclerosis (FSGS), and 17 healthy controls was determined. Children with SSNS were studied in relapse, during corticosteroid treatment, and in stable remission, off corticosteroid treatment. IL-12 was not detected in serum, urine, and in supernatants of unstimulated PBMC. IL-12 production by concanavalin A (Con A)-stimulated PBMC of children with SSNS and FSGS was not different from controls. IFN-gamma production by Con A-stimulated PBMC was decreased in children with relapsing SSNS, both in relapse and and during corticosteroid treatment. However, in stable remission it was similar to controls. Markedly decreased IFN-gamma production (P<0.001) was observed by pokeweed mitogen-stimulated PBMC of relapsing SSNS patients and moderately decreased production by PBMC of FSGS patients. This study has established a decreased production of IFN-gamma by PBMC of relapsing SSNS and FSGS patients, but does not allow differentiation between these two different conditions. IL-12 did not have a pathogenic role in either SSNS or FSGS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9745869     DOI: 10.1007/s004670050488

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  The efficiency of intraperitoneal high-dose immunoglobulin in experimental nephrotic syndrome.

Authors:  Seyhan Erisir; Halide Akbas; Mustafa Koyun; Sema Akman
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

Review 2.  The pediatric nephrotic syndrome spectrum: clinical homogeneity and molecular heterogeneity.

Authors:  Asher D Schachter
Journal:  Pediatr Transplant       Date:  2004-08

3.  Beneficial effect of triple treatment plus immunoglobulin in experimental nephrotic syndrome.

Authors:  Sema Akman; Salih Kalay; Bahar Akkaya; Mustafa Koyun; Halide Akbaş; Yunus Emre Baysal; Ayfer Gur Guven
Journal:  Pediatr Nephrol       Date:  2009-02-18       Impact factor: 3.714

4.  Polymorphisms in interleukin-4-related genes in patients with minimal change nephrotic syndrome.

Authors:  Yuka Ikeuchi; Yasuko Kobayashi; Hirokazu Arakawa; Michiko Suzuki; Kazushi Tamra; Akihiro Morikawa
Journal:  Pediatr Nephrol       Date:  2008-11-15       Impact factor: 3.714

5.  Up-regulation of interleukin-2 mRNA in children with idiopathic nephrotic syndrome.

Authors:  Hironobu Shimoyama; Mitsuru Nakajima; Hiroyuki Naka; Yoshiyuki Maruhashi; Hideki Akazawa; Taku Ueda; Masayuki Nishiguchi; Yoko Yamoto; Hidekazu Kamitsuji; Akira Yoshioka
Journal:  Pediatr Nephrol       Date:  2004-08-07       Impact factor: 3.714

Review 6.  A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome.

Authors:  Carlos E Araya; Clive H Wasserfall; Todd M Brusko; Wei Mu; Mark S Segal; Richard J Johnson; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

7.  Minimal-change disease secondary to etanercept.

Authors:  Mariko Koya; Raimund Pichler; J Ashley Jefferson
Journal:  Clin Kidney J       Date:  2012-08-16

Review 8.  Pathogenesis of minimal change nephrotic syndrome: an immunological concept.

Authors:  Seong Heon Kim; Se Jin Park; Kyoung Hee Han; Andreas Kronbichler; Moin A Saleem; Jun Oh; Beom Jin Lim; Jae Il Shin
Journal:  Korean J Pediatr       Date:  2016-05-31

Review 9.  Immunologic Changes Implicated in the Pathogenesis of Focal Segmental Glomerulosclerosis.

Authors:  Andreas Kronbichler; Johannes Leierer; Jun Oh; Björn Meijers; Jae Il Shin
Journal:  Biomed Res Int       Date:  2016-02-17       Impact factor: 3.411

10.  Truncation of C-mip (Tc-mip), a new proximal signaling protein, induces c-maf Th2 transcription factor and cytoskeleton reorganization.

Authors:  Philippe Grimbert; Asta Valanciute; Vincent Audard; André Pawlak; Sabine Le gouvelo; Philippe Lang; Patrick Niaudet; Albert Bensman; Georges Guellaën; Djillali Sahali
Journal:  J Exp Med       Date:  2003-08-25       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.